{"id":"W2522691612","doi":"10.1200/jco.2013.31.4_suppl.457","title":"Induction treatment in first-line with chemotherapy + bevacizumab (bev) in metastatic colorectal cancer: Results from the gercor-DREAM phase III study.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Charles-Le Moyne","funders":"","keywords":"Medicine; FOLFOX; FOLFIRI; Bevacizumab; Internal medicine; Oxaliplatin; Oncology; Neutropenia; Irinotecan; Colorectal cancer; Population; Erlotinib; Regimen; Surgery; Chemotherapy; Cancer; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001931203,0.0006671399,0.001925581,0.0002071917,0.0001809989,0.0006250452,0.0008981576,0.000645096,0.002545774],"category_scores_gemma":[0.0009666263,0.0003263614,0.001420563,0.0003052174,0.0004027806,0.0003979827,0.0003452787,0.001501975,0.0006471145],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009920029,"about_ca_system_score_gemma":0.001240277,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001389644,"about_ca_topic_score_gemma":0.004256094,"domain_scores_codex":[0.9993737,0.000364555,0.00003277868,0.00008064005,0.00006249424,0.0000857625],"domain_scores_gemma":[0.999347,0.0001095349,0.0001440353,0.000070924,0.00003247673,0.00029599],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7477708,0.03524572,0.02670055,0.001730895,0.003824455,0.0001799686,0.0001369696,0.002200577,0.01254533,0.0002062447,0.006738436,0.1627201],"study_design_scores_gemma":[0.6672491,0.2775599,0.04382745,0.0001523862,0.00178924,0.0005420437,0.00005444515,0.000961147,0.002126588,0.0001788978,0.005530365,0.00002852084],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9823518,0.01056362,0.0005402182,0.0003949022,0.0001461663,0.001277042,0.002070544,0.00009268276,0.002562944],"genre_scores_gemma":[0.97916,0.005525483,0.002030729,0.001169037,0.0001810615,0.00127699,0.008379844,0.000030298,0.002246623],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002545774,"threshold_uncertainty_score":0.01021332,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1235379580598882,"score_gpt":0.4627823637892175,"score_spread":0.3392444057293293,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}